Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BTK inhibitors
Pharma
ASH: Lilly defends survival data blemish in novel BTK trial win
The overall survival analysis created a bit of a problem for Lilly as the hazard ratio edged above 1 in favor of control.
Angus Liu
Dec 9, 2024 5:45pm
ASH: AstraZeneca proposes fixed-duration Calquence combos in CLL
Dec 8, 2024 11:00am
AstraZeneca trumpets new Calquence combos in CLL
Jul 29, 2024 10:25am
AZ clinches early Calquence win in untreated MCL
May 2, 2024 10:24am
As Imbruvica fails, Brukinsa wins FDA nod in follicular lymphoma
Mar 7, 2024 4:08pm
BeiGene added 1,400 employees as key cancer drugs expand
Feb 26, 2024 11:03am